FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108930291> ?p ?o ?g. }

• W2108930291 endingPage "1414" @default.
• W2108930291 startingPage "1409" @default.
• W2108930291 abstract "Purpose Vasomotor hot flashes are a common problem in menopausal women. Given concerns regarding estrogen and/or combined hormonal therapy, other treatment options are desired. Prior trials have confirmed that progestational agents and newer antidepressants effectively reduce hot flashes. This current trial compared a single intramuscular dose of medroxyprogesterone acetate (MPA), depot preparation, versus daily oral venlafaxine as treatment for hot flashes. Methods Women with bothersome hot flashes were entered onto this trial, were randomly assigned to treatment, and then had a baseline week where hot flash scores were recorded without treatment. They were then treated and observed for 6 weeks; daily diaries were used to measure hot flash frequencies and severities. There were 109 patients per each arm randomly assigned to receive MPA 400 mg intramuscularly for a single dose versus venlafaxine 37.5 mg per day for a week, then 75 mg per day. Results During the sixth week after random assignment, hot flash scores were reduced by 55% in the venlafaxine arm versus 79% in the MPA arm (P < .0001). In an intention-to-treat analysis, 46% of venlafaxine patients (50 of 109) compared with 74% of the MPA patients (81 of 109) had a decrease in hot flashes by more than 50% from baseline (P < .0001). Less toxicity was reported in the MPA arm. Conclusion A single MPA dose seems to be well tolerated and more effectively reduces hot flashes than does venlafaxine." @default.
• W2108930291 created "2016-06-24" @default.
• W2108930291 creator A5008767553 @default.
• W2108930291 creator A5029941846 @default.
• W2108930291 creator A5031000802 @default.
• W2108930291 creator A5033848572 @default.
• W2108930291 creator A5037766674 @default.
• W2108930291 creator A5040261194 @default.
• W2108930291 creator A5051200321 @default.
• W2108930291 creator A5064449830 @default.
• W2108930291 creator A5072257104 @default.
• W2108930291 creator A5081957836 @default.
• W2108930291 creator A5085556853 @default.
• W2108930291 date "2006-03-20" @default.
• W2108930291 modified "2023-10-16" @default.
• W2108930291 title "Phase III Comparison of Depomedroxyprogesterone Acetate to Venlafaxine for Managing Hot Flashes: North Central Cancer Treatment Group Trial N99C7" @default.
• W2108930291 cites W1586699954 @default.
• W2108930291 cites W1593442063 @default.
• W2108930291 cites W1891596808 @default.
• W2108930291 cites W1925973161 @default.
• W2108930291 cites W1971096261 @default.
• W2108930291 cites W1980562610 @default.
• W2108930291 cites W1995378011 @default.
• W2108930291 cites W1995772131 @default.
• W2108930291 cites W1998117916 @default.
• W2108930291 cites W2000366267 @default.
• W2108930291 cites W2008635153 @default.
• W2108930291 cites W2031911149 @default.
• W2108930291 cites W2039874252 @default.
• W2108930291 cites W2044777610 @default.
• W2108930291 cites W2054339472 @default.
• W2108930291 cites W2064671008 @default.
• W2108930291 cites W2075768688 @default.
• W2108930291 cites W2104801251 @default.
• W2108930291 cites W2111042503 @default.
• W2108930291 cites W2112317094 @default.
• W2108930291 cites W2133675074 @default.
• W2108930291 cites W2148120400 @default.
• W2108930291 cites W2149860264 @default.
• W2108930291 cites W2321102288 @default.
• W2108930291 cites W2607238143 @default.
• W2108930291 doi "https://doi.org/10.1200/jco.2005.04.7324" @default.
• W2108930291 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16505409" @default.
• W2108930291 hasPublicationYear "2006" @default.
• W2108930291 type Work @default.
• W2108930291 sameAs 2108930291 @default.
• W2108930291 citedByCount "103" @default.
• W2108930291 countsByYear W21089302912012 @default.
• W2108930291 countsByYear W21089302912013 @default.
• W2108930291 countsByYear W21089302912014 @default.
• W2108930291 countsByYear W21089302912015 @default.
• W2108930291 countsByYear W21089302912016 @default.
• W2108930291 countsByYear W21089302912017 @default.
• W2108930291 countsByYear W21089302912018 @default.
• W2108930291 countsByYear W21089302912019 @default.
• W2108930291 countsByYear W21089302912020 @default.
• W2108930291 countsByYear W21089302912021 @default.
• W2108930291 countsByYear W21089302912022 @default.
• W2108930291 countsByYear W21089302912023 @default.
• W2108930291 crossrefType "journal-article" @default.
• W2108930291 hasAuthorship W2108930291A5008767553 @default.
• W2108930291 hasAuthorship W2108930291A5029941846 @default.
• W2108930291 hasAuthorship W2108930291A5031000802 @default.
• W2108930291 hasAuthorship W2108930291A5033848572 @default.
• W2108930291 hasAuthorship W2108930291A5037766674 @default.
• W2108930291 hasAuthorship W2108930291A5040261194 @default.
• W2108930291 hasAuthorship W2108930291A5051200321 @default.
• W2108930291 hasAuthorship W2108930291A5064449830 @default.
• W2108930291 hasAuthorship W2108930291A5072257104 @default.
• W2108930291 hasAuthorship W2108930291A5081957836 @default.
• W2108930291 hasAuthorship W2108930291A5085556853 @default.
• W2108930291 hasConcept C121608353 @default.
• W2108930291 hasConcept C126322002 @default.
• W2108930291 hasConcept C168563851 @default.
• W2108930291 hasConcept C2776128548 @default.
• W2108930291 hasConcept C2776306185 @default.
• W2108930291 hasConcept C2776466888 @default.
• W2108930291 hasConcept C2777164284 @default.
• W2108930291 hasConcept C2779177272 @default.
• W2108930291 hasConcept C2781161787 @default.
• W2108930291 hasConcept C2909532165 @default.
• W2108930291 hasConcept C42219234 @default.
• W2108930291 hasConcept C530470458 @default.
• W2108930291 hasConcept C535046627 @default.
• W2108930291 hasConcept C71924100 @default.
• W2108930291 hasConceptScore W2108930291C121608353 @default.
• W2108930291 hasConceptScore W2108930291C126322002 @default.
• W2108930291 hasConceptScore W2108930291C168563851 @default.
• W2108930291 hasConceptScore W2108930291C2776128548 @default.
• W2108930291 hasConceptScore W2108930291C2776306185 @default.
• W2108930291 hasConceptScore W2108930291C2776466888 @default.
• W2108930291 hasConceptScore W2108930291C2777164284 @default.
• W2108930291 hasConceptScore W2108930291C2779177272 @default.
• W2108930291 hasConceptScore W2108930291C2781161787 @default.
• W2108930291 hasConceptScore W2108930291C2909532165 @default.
• W2108930291 hasConceptScore W2108930291C42219234 @default.
• W2108930291 hasConceptScore W2108930291C530470458 @default.
• W2108930291 hasConceptScore W2108930291C535046627 @default.

• next